Market Overview

From Biogen Call: Eloctate Could Be Facing Potential Approval Delay

Related BIIB
Alexion Pharmaceuticals Q2 Earnings In Line; Revises View
Illumina (ILMN) Tops Q2 Earnings & Revenues, Ups Guidance
Don't Panic Over Recent Tech Turmoil (Fox Business)

Posted-In: News FDA

 

Most Popular

Related Articles (BIIB)

Around the Web, We're Loving...

Partner Network

Get Benzinga's Newsletters